Nonhuman Primate Reagent Resource (U24 Clinical Trial Not Allowed)

forecasted

The National Institute of Allergy and Infectious Diseases (NIAID) intends to publish a Notice of Funding Opportunity (NOFO) to solicit applications to continue support for a nonhuman primate (NHP) reagent resource that enables rigorous and reproducible research in NHP models through the development, production, and distribution of NHP-specific immunologic reagents that are not commercially available or, if commercially available, are not optimized for use in NHPs. The over-arching goal is to accelerate cures, vaccines, and treatments for immune-mediated diseases and emerging and reemerging infectious diseases by facilitating robust preclinical research in NHPs. This NOFO will utilize the U24 activity code. Applications are not being solicited at this time. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects. Investigators with expertise and insights into this area of NHP research are encouraged to begin to consider applying for this new NOFO. In addition, collaborative investigations will be encouraged, and these investigators should also begin considering applying for this NOFO.